Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35]

IF 4.5 2区医学 Q2 IMMUNOLOGY

Journal of Microbiology Immunology and Infection Pub Date : 2024-02-01 DOI:10.1016/j.jmii.2023.10.003

Shao-Huan Lan , Chih-Cheng Lai , Shen-Peng Chang , Chun-Chun Hsu , Cheng-Hsin Chen , Ya-Hui Wang , Yueh Lan Huang , Cheng-Yi Wang , You-Shuei Lin

引用次数: 0

查看原文本刊更多论文

【J Microbiol Immunol Infect 55（1）（2022）26-35】勘误表。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Microbiology Immunology and Infection IMMUNOLOGY-INFECTIOUS DISEASES

CiteScore

15.90

自引率

5.40%

发文量

159

审稿时长

67 days

期刊介绍： Journal of Microbiology Immunology and Infection is an open access journal, committed to disseminating information on the latest trends and advances in microbiology, immunology, infectious diseases and parasitology. Article types considered include perspectives, review articles, original articles, brief reports and correspondence. With the aim of promoting effective and accurate scientific information, an expert panel of referees constitutes the backbone of the peer-review process in evaluating the quality and content of manuscripts submitted for publication.